Latest news with #RACCOONHOLDINGS
Yahoo
15-04-2025
- Business
- Yahoo
3 Asian Stocks Estimated To Be Trading At Discounts Of Up To 44%
As global trade tensions escalate, Asian markets have faced significant volatility, with investors closely monitoring the economic impacts of ongoing tariff disputes. Amidst this uncertainty, identifying undervalued stocks can present opportunities for investors seeking potential value in a fluctuating market environment. Name Current Price Fair Value (Est) Discount (Est) Ningbo Sanxing Medical ElectricLtd (SHSE:601567) CN¥26.92 CN¥53.13 49.3% RACCOON HOLDINGS (TSE:3031) ¥855.00 ¥1705.77 49.9% Nishi-Nippon Financial Holdings (TSE:7189) ¥1844.00 ¥3655.42 49.6% People & Technology (KOSDAQ:A137400) ₩39250.00 ₩77062.66 49.1% Micro-Star International (TWSE:2377) NT$133.50 NT$265.53 49.7% Bairong (SEHK:6608) HK$6.85 HK$13.51 49.3% AeroEdge (TSE:7409) ¥1895.00 ¥3726.08 49.1% BIKE O (TSE:3377) ¥373.00 ¥730.90 49% World Fitness Services (TWSE:2762) NT$80.00 NT$156.52 48.9% giftee (TSE:4449) ¥1485.00 ¥2960.11 49.8% Click here to see the full list of 264 stocks from our Undervalued Asian Stocks Based On Cash Flows screener. We're going to check out a few of the best picks from our screener tool. Overview: ALTEOGEN Inc. is a biotechnology company that develops long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars, with a market cap of ₩20.63 trillion. Operations: The company's revenue stems from its biotechnology segment, amounting to ₩102.85 million. Estimated Discount To Fair Value: 44% ALTEOGEN is trading at a significant discount, 44% below its estimated fair value of ₩691,476.79, making it highly undervalued based on discounted cash flow analysis. The company's earnings and revenue are expected to grow significantly faster than the Korean market average over the next three years. Recent private placements have strengthened its financial position, potentially supporting future growth initiatives and enhancing cash flows. Insights from our recent growth report point to a promising forecast for ALTEOGEN's business outlook. Take a closer look at ALTEOGEN's balance sheet health here in our report. Overview: Xiaomi Corporation is an investment holding company that offers hardware and software services both in Mainland China and internationally, with a market cap of HK$1.12 trillion. Operations: The company generates revenue from several segments, including Smartphones (CN¥191.76 billion), Internet Services (CN¥34.12 billion), IoT and Lifestyle Products (CN¥104.10 billion), and Smart EV and Other New Initiatives (CN¥32.75 billion). Estimated Discount To Fair Value: 25.7% Xiaomi is trading at a significant discount, 25.7% below its estimated fair value of HK$58.12, indicating it's undervalued based on discounted cash flow analysis. The company's earnings are forecast to grow significantly faster than the Hong Kong market over the next three years. Recent strategic partnerships in EV charging and a follow-on equity offering of HK$42.6 billion further bolster its financial position and growth prospects in the expanding NEV market. The growth report we've compiled suggests that Xiaomi's future prospects could be on the up. Get an in-depth perspective on Xiaomi's balance sheet by reading our health report here. Overview: Singapore Technologies Engineering Ltd is a global technology, defence, and engineering company with a market cap of SGD21.13 billion. Operations: The company's revenue is primarily derived from three segments: Commercial Aerospace (SGD4.44 billion), Urban Solutions & Satcom (SGD2.01 billion), and Defence & Public Security (SGD4.97 billion). Estimated Discount To Fair Value: 37.4% Singapore Technologies Engineering is trading at a 37.4% discount to its estimated fair value of S$10.81, highlighting potential undervaluation based on cash flows. The company reported strong earnings growth of 19.7% last year and forecasts suggest continued earnings growth at 11.6% annually, outpacing the Singapore market's average. Despite carrying high debt levels, its strategic initiatives and dividend policy adjustments aim to enhance shareholder returns while maintaining financial stability amid moderate revenue growth expectations. Our earnings growth report unveils the potential for significant increases in Singapore Technologies Engineering's future results. Delve into the full analysis health report here for a deeper understanding of Singapore Technologies Engineering. Click here to access our complete index of 264 Undervalued Asian Stocks Based On Cash Flows. Invested in any of these stocks? Simplify your portfolio management with Simply Wall St and stay ahead with our alerts for any critical updates on your stocks. Enhance your investing ability with the Simply Wall St app and enjoy free access to essential market intelligence spanning every continent. Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include KOSDAQ:A196170 SEHK:1810 and SGX:S63. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Sign in to access your portfolio
Yahoo
15-04-2025
- Business
- Yahoo
3 Asian Stocks Estimated To Be Trading At Discounts Of Up To 44%
As global trade tensions escalate, Asian markets have faced significant volatility, with investors closely monitoring the economic impacts of ongoing tariff disputes. Amidst this uncertainty, identifying undervalued stocks can present opportunities for investors seeking potential value in a fluctuating market environment. Name Current Price Fair Value (Est) Discount (Est) Ningbo Sanxing Medical ElectricLtd (SHSE:601567) CN¥26.92 CN¥53.13 49.3% RACCOON HOLDINGS (TSE:3031) ¥855.00 ¥1705.77 49.9% Nishi-Nippon Financial Holdings (TSE:7189) ¥1844.00 ¥3655.42 49.6% People & Technology (KOSDAQ:A137400) ₩39250.00 ₩77062.66 49.1% Micro-Star International (TWSE:2377) NT$133.50 NT$265.53 49.7% Bairong (SEHK:6608) HK$6.85 HK$13.51 49.3% AeroEdge (TSE:7409) ¥1895.00 ¥3726.08 49.1% BIKE O (TSE:3377) ¥373.00 ¥730.90 49% World Fitness Services (TWSE:2762) NT$80.00 NT$156.52 48.9% giftee (TSE:4449) ¥1485.00 ¥2960.11 49.8% Click here to see the full list of 264 stocks from our Undervalued Asian Stocks Based On Cash Flows screener. We're going to check out a few of the best picks from our screener tool. Overview: ALTEOGEN Inc. is a biotechnology company that develops long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars, with a market cap of ₩20.63 trillion. Operations: The company's revenue stems from its biotechnology segment, amounting to ₩102.85 million. Estimated Discount To Fair Value: 44% ALTEOGEN is trading at a significant discount, 44% below its estimated fair value of ₩691,476.79, making it highly undervalued based on discounted cash flow analysis. The company's earnings and revenue are expected to grow significantly faster than the Korean market average over the next three years. Recent private placements have strengthened its financial position, potentially supporting future growth initiatives and enhancing cash flows. Insights from our recent growth report point to a promising forecast for ALTEOGEN's business outlook. Take a closer look at ALTEOGEN's balance sheet health here in our report. Overview: Xiaomi Corporation is an investment holding company that offers hardware and software services both in Mainland China and internationally, with a market cap of HK$1.12 trillion. Operations: The company generates revenue from several segments, including Smartphones (CN¥191.76 billion), Internet Services (CN¥34.12 billion), IoT and Lifestyle Products (CN¥104.10 billion), and Smart EV and Other New Initiatives (CN¥32.75 billion). Estimated Discount To Fair Value: 25.7% Xiaomi is trading at a significant discount, 25.7% below its estimated fair value of HK$58.12, indicating it's undervalued based on discounted cash flow analysis. The company's earnings are forecast to grow significantly faster than the Hong Kong market over the next three years. Recent strategic partnerships in EV charging and a follow-on equity offering of HK$42.6 billion further bolster its financial position and growth prospects in the expanding NEV market. The growth report we've compiled suggests that Xiaomi's future prospects could be on the up. Get an in-depth perspective on Xiaomi's balance sheet by reading our health report here. Overview: Singapore Technologies Engineering Ltd is a global technology, defence, and engineering company with a market cap of SGD21.13 billion. Operations: The company's revenue is primarily derived from three segments: Commercial Aerospace (SGD4.44 billion), Urban Solutions & Satcom (SGD2.01 billion), and Defence & Public Security (SGD4.97 billion). Estimated Discount To Fair Value: 37.4% Singapore Technologies Engineering is trading at a 37.4% discount to its estimated fair value of S$10.81, highlighting potential undervaluation based on cash flows. The company reported strong earnings growth of 19.7% last year and forecasts suggest continued earnings growth at 11.6% annually, outpacing the Singapore market's average. Despite carrying high debt levels, its strategic initiatives and dividend policy adjustments aim to enhance shareholder returns while maintaining financial stability amid moderate revenue growth expectations. Our earnings growth report unveils the potential for significant increases in Singapore Technologies Engineering's future results. Delve into the full analysis health report here for a deeper understanding of Singapore Technologies Engineering. Click here to access our complete index of 264 Undervalued Asian Stocks Based On Cash Flows. Invested in any of these stocks? Simplify your portfolio management with Simply Wall St and stay ahead with our alerts for any critical updates on your stocks. Enhance your investing ability with the Simply Wall St app and enjoy free access to essential market intelligence spanning every continent. Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include KOSDAQ:A196170 SEHK:1810 and SGX:S63. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@
Yahoo
14-04-2025
- Business
- Yahoo
Global Market Insights On 3 Stocks Estimated To Be Trading Below Fair Value
In the midst of escalating trade tensions and volatile market conditions, global indices have experienced significant fluctuations, with U.S. stocks rebounding after a tumultuous week marked by tariff announcements. Amidst this uncertainty, identifying stocks that are trading below their fair value can offer potential opportunities for investors seeking to navigate these challenging times. Name Current Price Fair Value (Est) Discount (Est) Alexander Marine (TWSE:8478) NT$140.00 NT$279.61 49.9% RACCOON HOLDINGS (TSE:3031) ¥858.00 ¥1705.49 49.7% Nishi-Nippon Financial Holdings (TSE:7189) ¥1849.00 ¥3655.43 49.4% LPP (WSE:LPP) PLN15300.00 PLN30532.59 49.9% Hyundai Rotem (KOSE:A064350) ₩104900.00 ₩209201.36 49.9% People & Technology (KOSDAQ:A137400) ₩39250.00 ₩76934.18 49% Micro-Star International (TWSE:2377) NT$133.00 NT$265.46 49.9% Net Insight (OM:NETI B) SEK4.58 SEK9.05 49.4% giftee (TSE:4449) ¥1483.00 ¥2946.17 49.7% Wall to Wall Group (OM:WTW A) SEK56.00 SEK111.38 49.7% Click here to see the full list of 479 stocks from our Undervalued Global Stocks Based On Cash Flows screener. Below we spotlight a couple of our favorites from our exclusive screener. Overview: Hyundai Rotem Company manufactures and sells railway vehicles, defense systems, and plants and machinery both in South Korea and internationally, with a market cap of ₩11.12 billion. Operations: The company's revenue is derived from three main segments: Rail Solution at ₩1.50 billion, Defense Solution at ₩2.37 billion, and Plant Segment at ₩515.79 million. Estimated Discount To Fair Value: 49.9% Hyundai Rotem is trading 49.9% below its estimated fair value of ₩209,201.36, making it significantly undervalued based on cash flows. The company reported robust earnings growth of 152.7% last year and forecasts indicate a continued annual profit growth rate of 25.6%, outpacing the KR market's expected growth. Despite high share price volatility, Hyundai Rotem's revenue is projected to grow at 13.5% annually, surpassing the broader market's rate of 7.5%. The growth report we've compiled suggests that Hyundai Rotem's future prospects could be on the up. Unlock comprehensive insights into our analysis of Hyundai Rotem stock in this financial health report. Overview: Zhejiang China Commodities City Group Co., Ltd. operates an online trading platform in China, focusing on development and management services, with a market cap of CN¥78.91 billion. Operations: The company generates revenue primarily through the development, management, and operation of an online trading platform in China. Estimated Discount To Fair Value: 38.5% Zhejiang China Commodities City Group, trading at CN¥14.81, is undervalued against its fair value estimate of CN¥24.10, with a recent earnings growth of 46%. Analysts forecast continued strong earnings growth at 26.82% annually, outpacing the Chinese market's average. Despite an unstable dividend history, the company's revenue and net income have shown robust year-over-year increases in recent quarters, reinforcing its potential as an undervalued investment based on cash flows. Our expertly prepared growth report on Zhejiang China Commodities City Group implies its future financial outlook may be stronger than recent results. Navigate through the intricacies of Zhejiang China Commodities City Group with our comprehensive financial health report here. Overview: HOYA Corporation is a med-tech company that offers high-tech and medical products globally, with a market cap of ¥5.13 trillion. Operations: The company's revenue is primarily generated from its Life Care segment, contributing ¥547.68 billion, and its Information Technology segment, contributing ¥294.89 billion. Estimated Discount To Fair Value: 25.8% HOYA, trading at ¥15,235, is undervalued relative to its fair value estimate of ¥20,532.44. The company recently completed a share buyback program worth ¥49.99 billion to enhance shareholder returns and capital efficiency. With earnings growth projected at 10.9% annually and revenue growth surpassing the JP market average, HOYA's strong cash flow position makes it an attractive consideration for investors seeking undervalued opportunities based on cash flows. Our earnings growth report unveils the potential for significant increases in HOYA's future results. Click to explore a detailed breakdown of our findings in HOYA's balance sheet health report. Unlock our comprehensive list of 479 Undervalued Global Stocks Based On Cash Flows by clicking here. Are these companies part of your investment strategy? Use Simply Wall St to consolidate your holdings into a portfolio and gain insights with our comprehensive analysis tools. Elevate your portfolio with Simply Wall St, the ultimate app for investors seeking global market coverage. Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include KOSE:A064350 SHSE:600415 and TSE:7741. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Sign in to access your portfolio
Yahoo
28-03-2025
- Business
- Yahoo
3 Asian Stocks Estimated To Be Up To 43.1% Below Intrinsic Value
As global markets navigate a landscape of economic uncertainty and shifting policies, Asian stocks present intriguing opportunities for investors seeking value. In this environment, identifying undervalued stocks—those trading below their intrinsic value—can be a prudent strategy to potentially capitalize on market inefficiencies. Name Current Price Fair Value (Est) Discount (Est) Consun Pharmaceutical Group (SEHK:1681) HK$8.87 HK$17.63 49.7% RACCOON HOLDINGS (TSE:3031) ¥957.00 ¥1890.86 49.4% Sichuan Kexin Mechanical and Electrical EquipmentLtd (SZSE:300092) CN¥13.10 CN¥25.69 49% TechnoPro Holdings (TSE:6028) ¥3306.00 ¥6593.98 49.9% S Foods (TSE:2292) ¥2556.00 ¥5084.09 49.7% Bide Pharmatech (SHSE:688073) CN¥54.00 CN¥106.91 49.5% Takara Bio (TSE:4974) ¥866.00 ¥1698.81 49% ALUX (KOSDAQ:A475580) ₩11250.00 ₩22243.70 49.4% Kinsus Interconnect Technology (TWSE:3189) NT$93.10 NT$182.94 49.1% Zhejiang Juhua (SHSE:600160) CN¥24.28 CN¥47.60 49% Click here to see the full list of 272 stocks from our Undervalued Asian Stocks Based On Cash Flows screener. Below we spotlight a couple of our favorites from our exclusive screener. Overview: Smoore International Holdings Limited is an investment holding company that provides vaping technology solutions and has a market cap of HK$83.08 billion. Operations: The company generates revenue primarily from the sale of APV and vaping devices and components, amounting to CN¥11.80 billion. Estimated Discount To Fair Value: 13.7% Smoore International Holdings is trading at HK$13.66, below its estimated fair value of HK$15.83, suggesting potential undervaluation based on cash flows. Earnings are forecast to grow significantly at 24.94% annually, outpacing the Hong Kong market's growth rate. However, recent financial results show a decline in net income from CNY 1,645.09 million to CNY 1,303.26 million year-over-year despite increased sales revenue to CNY 11.80 billion from CNY 11.20 billion. Insights from our recent growth report point to a promising forecast for Smoore International Holdings' business outlook. Click here and access our complete balance sheet health report to understand the dynamics of Smoore International Holdings. Overview: Ningbo Sanxing Medical Electric Co., Ltd. manufactures and sells power distribution and utilization systems both in China and internationally, with a market cap of CN¥41.34 billion. Operations: The company generates revenue from the manufacture and sale of power distribution and utilization systems, serving both domestic and international markets. Estimated Discount To Fair Value: 43.1% Ningbo Sanxing Medical Electric Ltd. is trading at CN¥29.37, significantly below its fair value estimate of CN¥51.66, highlighting potential undervaluation based on cash flows. Earnings grew by 28.5% last year and are forecast to grow 21.6% annually, though slower than the broader Chinese market's growth rate of 24.8%. Despite an unstable dividend history, revenue growth is expected to outpace the market at 21.9% per year, with analysts predicting a stock price increase of 37.8%. Our growth report here indicates Ningbo Sanxing Medical ElectricLtd may be poised for an improving outlook. Unlock comprehensive insights into our analysis of Ningbo Sanxing Medical ElectricLtd stock in this financial health report. Overview: Ningbo Orient Wires & Cables Co., Ltd. offers land and subsea cable solutions both in China and internationally, with a market cap of CN¥34.13 billion. Operations: The company's revenue segments include land cable solutions generating CN¥3.45 billion and subsea cable solutions contributing CN¥2.78 billion. Estimated Discount To Fair Value: 26.8% Ningbo Orient Wires & Cables Ltd. trades at CN¥49.55, below its estimated fair value of CN¥67.65, suggesting undervaluation based on cash flows. Earnings are forecast to grow significantly at 30.4% annually, outpacing the Chinese market's 24.8%. Recent earnings showed a modest increase in net income to CN¥1 billion from last year, and analysts expect a stock price rise of 29.2%, despite slower revenue growth and an unstable dividend track record. Our earnings growth report unveils the potential for significant increases in Ningbo Orient Wires & CablesLtd's future results. Get an in-depth perspective on Ningbo Orient Wires & CablesLtd's balance sheet by reading our health report here. Get an in-depth perspective on all 272 Undervalued Asian Stocks Based On Cash Flows by using our screener here. Shareholder in one or more of these companies? Ensure you're never caught off-guard by adding your portfolio in Simply Wall St for timely alerts on significant stock developments. Elevate your portfolio with Simply Wall St, the ultimate app for investors seeking global market coverage. Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include SEHK:6969 SHSE:601567 and SHSE:603606. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@
Yahoo
27-03-2025
- Business
- Yahoo
3 Global Stocks Estimated To Be 34.7% To 49.9% Below Intrinsic Value
In the midst of heightened uncertainty and mixed economic signals, global markets have shown resilience with U.S. stocks closing higher and European indices snapping a streak of losses. As investors navigate this complex landscape, identifying undervalued stocks becomes crucial; these are companies whose market prices fall significantly below their intrinsic value, offering potential opportunities for growth even amid fluctuating market conditions. Name Current Price Fair Value (Est) Discount (Est) Absolent Air Care Group (OM:ABSO) SEK256.00 SEK508.82 49.7% RACCOON HOLDINGS (TSE:3031) ¥957.00 ¥1890.86 49.4% Romsdal Sparebank (OB:ROMSB) NOK130.70 NOK258.18 49.4% TechnoPro Holdings (TSE:6028) ¥3306.00 ¥6593.98 49.9% S Foods (TSE:2292) ¥2556.00 ¥5084.09 49.7% Bide Pharmatech (SHSE:688073) CN¥54.00 CN¥106.91 49.5% APAC Realty (SGX:CLN) SGD0.43 SGD0.85 49.4% ALUX (KOSDAQ:A475580) ₩11250.00 ₩22243.70 49.4% dormakaba Holding (SWX:DOKA) CHF684.00 CHF1352.22 49.4% Dino Polska (WSE:DNP) PLN445.20 PLN887.95 49.9% Click here to see the full list of 498 stocks from our Undervalued Global Stocks Based On Cash Flows screener. Here's a peek at a few of the choices from the screener. Overview: Megacable Holdings S. A. B. de C. V., along with its subsidiaries, operates in the installation, operation, and maintenance of cable television, internet, and telephone signal distribution systems with a market cap of MX$37.09 billion. Operations: Revenue segments for Megacable Holdings include cable television, internet, and telephone signal distribution systems. Estimated Discount To Fair Value: 36.1% Megacable Holdings S. A. B. de C. V., trading at MX$43.2, is significantly undervalued based on discounted cash flow analysis with a fair value estimate of MX$67.59, representing a 36% discount to its intrinsic value. Despite low forecasted return on equity and inadequate interest coverage, projected earnings growth of 20.8% annually outpaces the Mexican market average, suggesting potential for substantial future cash flows despite recent declines in net income and earnings per share. Our growth report here indicates Megacable Holdings S. A. B. de C. V may be poised for an improving outlook. Unlock comprehensive insights into our analysis of Megacable Holdings S. A. B. de C. V stock in this financial health report. Overview: Saudi Kayan Petrochemical Company manufactures and sells chemicals, polymers, and specialty products, with a market cap of SAR9 billion. Operations: The company's revenue is primarily derived from its petrochemicals segment, totaling SAR8.73 billion. Estimated Discount To Fair Value: 34.7% Saudi Kayan Petrochemical, trading at SAR6.04, is undervalued with a fair value estimate of SAR9.25, offering a 34.7% discount to intrinsic value. Despite low forecasted return on equity and recent net losses of SAR1.8 billion, the company is expected to achieve profitability within three years and grow earnings by 76.84% annually, outpacing average market growth and suggesting potential for improved cash flows relative to peers in the industry. Upon reviewing our latest growth report, Saudi Kayan Petrochemical's projected financial performance appears quite optimistic. Click here and access our complete balance sheet health report to understand the dynamics of Saudi Kayan Petrochemical. Overview: TechnoPro Holdings, Inc. operates as a temporary staffing and contract work company both in Japan and internationally, with a market cap of ¥341.33 billion. Operations: The company's revenue segments include ¥17.83 billion from R&D Outsourcing Business, ¥24.46 billion from Construction Management Outsourcing, and ¥4.83 billion from Domestic Other Business, along with ¥25.42 billion generated by Overseas Businesses. Estimated Discount To Fair Value: 49.9% TechnoPro Holdings is trading at ¥3,306, significantly undervalued with a fair value estimate of ¥6,593.98, reflecting a discount of over 20%. Despite an unstable dividend track record, the company declared an interim dividend of JPY 30.00 per share and reaffirmed year-end guidance of JPY 60.00 per share for fiscal 2025. Earnings are forecast to grow at 13.22% annually, outpacing the Japanese market's average growth rate and supporting its undervaluation based on cash flows. Our earnings growth report unveils the potential for significant increases in TechnoPro Holdings' future results. Get an in-depth perspective on TechnoPro Holdings' balance sheet by reading our health report here. Investigate our full lineup of 498 Undervalued Global Stocks Based On Cash Flows right here. Invested in any of these stocks? Simplify your portfolio management with Simply Wall St and stay ahead with our alerts for any critical updates on your stocks. Streamline your investment strategy with Simply Wall St's app for free and benefit from extensive research on stocks across all corners of the world. Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include BMV:MEGA CPO SASE:2350 and TSE:6028. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@
